Skip to main content

NY Talc Trial, J&J Hit With $300M In Punitive Damages

NY Talc Trial, J&J Hit With $300M In Punitive Damages

NY Talc Trial, J&J Hit With $300M In Punitive Damages

Introduction

J&J has been hit with $300M in punitive damages over a talcum powder lawsuit, on Friday, following a recent verdict held in NY.

A 66-year old woman and her husband had filed a lawsuit against J&J for her pleural mesothelioma, a cancer of the lining of the lungs in 2017. On May 21, 2019, a New York jury granted $25 million in compensatory damages to the plaintiffs, claiming the company was responsible for her mesothelioma but did not finalize on the punitive damages against the company. The NY jury finalized $300 million in punitive damages on Friday, adding the total verdict to $325 million. According to a J&J spokesperson, the company will appeal against the verdict.

J&J is facing nearly 14,000 similar allegations against its talc-based products. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!